These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2273084)

  • 1. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state interaction between amiodarone and phenytoin in normal subjects.
    Nolan PE; Erstad BL; Hoyer GL; Bliss M; Gear K; Marcus FI
    Am J Cardiol; 1990 May; 65(18):1252-7. PubMed ID: 2337037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers.
    Nolan PE; Marcus FI; Hoyer GL; Bliss M; Gear K
    Clin Pharmacol Ther; 1989 Jul; 46(1):43-50. PubMed ID: 2743707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.
    Kotake T; Takada M; Goto T; Komamura K; Kamakura S; Morishita H
    J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone pharmacokinetics in coronary patients: differences between acute and one-month chronic dosing.
    Poirier JM; Escoubet B; Jaillon P; Coumel P; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):67-72. PubMed ID: 3396616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and theophylline metabolism: effects of phenytoin.
    Crowley JJ; Cusack BJ; Jue SG; Koup JR; Vestal RE
    Clin Pharmacol Ther; 1987 Sep; 42(3):334-40. PubMed ID: 3621789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population.
    Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K
    Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects.
    Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H
    Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone pharmacokinetics.
    Holt DW; Tucker GT; Jackson PR; Storey GC
    Am Heart J; 1983 Oct; 106(4 Pt 2):840-7. PubMed ID: 6613830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
    Santostasi G; Fantin M; Maragno I; Gaion RM; Basadonna O; Dalla-Volta S
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):385-90. PubMed ID: 2438499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function.
    Vadiei K; O'Rangers EA; Klamerus KJ; Kluger J; Kazierad DJ; Leese PT; Chow MS; Zimmerman JJ
    J Clin Pharmacol; 1996 Aug; 36(8):720-7. PubMed ID: 8877676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.